2010
DOI: 10.1016/j.ejphar.2010.08.039
|View full text |Cite
|
Sign up to set email alerts
|

Activity of a new hydrogen sulfide-releasing aspirin (ACS14) on pathological cardiovascular alterations induced by glutathione depletion in rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
33
0
1

Year Published

2012
2012
2023
2023

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 48 publications
(36 citation statements)
references
References 25 publications
1
33
0
1
Order By: Relevance
“…In full agreement with our in vitro findings in human blood, oral treatment with ACS14 in mice, which has previously been shown to reduce aspirin-dependent gastrointestinal damage 3,21 in rodents, potently inhibited COX and consequently arachidonic acid-dependent platelet aggregation. Platelet aggregation in blood drawn from ACS14-but not aspirintreated animals was also significantly decreased on ADP stimulation, indicating that the COX-independent platelet inhibitory effects of ACS14 were preserved even after oral treatment and that findings in mouse and human platelets were alike.…”
Section: Discussionsupporting
confidence: 80%
See 1 more Smart Citation
“…In full agreement with our in vitro findings in human blood, oral treatment with ACS14 in mice, which has previously been shown to reduce aspirin-dependent gastrointestinal damage 3,21 in rodents, potently inhibited COX and consequently arachidonic acid-dependent platelet aggregation. Platelet aggregation in blood drawn from ACS14-but not aspirintreated animals was also significantly decreased on ADP stimulation, indicating that the COX-independent platelet inhibitory effects of ACS14 were preserved even after oral treatment and that findings in mouse and human platelets were alike.…”
Section: Discussionsupporting
confidence: 80%
“…ACS14 also preserved endothelial function in an animal model of metabolic syndrome and ischemiareperfusion injury by modulating levels of glutathione and homocysteine. 21,22 The beneficial vascular effects of ACS14 observed in animal studies raise the question whether this compound exerts the same antiaggregatory effects on platelets as aspirin or whether it may combine them with previously described antiaggregatory effects of H 2 S 23,24 and thereby exceed the inhibitory effects reached by aspirin alone.…”
mentioning
confidence: 99%
“…These findings suggest that the advantages of ACS14 in gastric protection are likely related to the enhanced H 2 S formation. ACS14 has also been shown to have strong protective effects against pathological cardiovascular alterations induced by buthionine sulfoximine (BSO), a GSH-synthase inhibitor (Rossoni et al 2010). In this study, 7-day BSO treatment increased rats' systolic blood pressure and lowered their heart rates.…”
Section: 3mentioning
confidence: 90%
“…ACS14 and ACS21 are derivatives of aspirin and salicylic acid, respectively. Both compounds reduce hypertension and lower plasma levels of thromboxane B2 and insulin induced by glutathione depletion (54). S-diclofenac (ACS-15) efficiently suppresses LPS-induced inflammation with less gastric toxicity than parental diclofenac.…”
Section: H 2 S-based Therapeuticsmentioning
confidence: 99%